4//SEC Filing
Saad Mark E 4
Accession 0001209191-23-016453
CIK 0001579428other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:12 PM ET
Size
5.4 KB
Accession
0001209191-23-016453
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-02+2,224→ 2,224 totalExercise: $65.32From: 2023-03-02Exp: 2033-03-01→ Common Stock (2,224 underlying)
Footnotes (1)
- [F1]Represents 2,224 options elected to be received in lieu of cash compensation earned in 2022. All of such options are immediately exercisable.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001295913
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:12 PM ET
- Size
- 5.4 KB